Abstract
Research question How accurate is minimally invasive assessment of endometrial receptivity from uterine fluid extracellular vesicles (UF-EVs) using only 68 RNA biomarkers.
Study design Assessment of endometrial receptivity by applying the beREADY computational model on transcriptomic data derived from UF-EVs during the pre-receptive (LH+2) and receptive phases (LH+7) of a natural cycle.
Results beREADY housekeeping gene transcript levels in UF-EV are not significantly different between LH+2 and LH+7 UF-EVs. Endometrial receptivity can be assessed from UF-EV transcriptomic data using beREADY computational model with specificity of 100% and sensitivity of 75%.
Conclusion beREADY computational model can be used on UF-EVs instead of endometrial tissue biopsy to assess endometrial receptivity. However, further development is needed to fine-tune the model to show that this model can also be used on UF-EV samples from women undergoing hormone-replacement therapy.
Competing Interest Statement
Disclosure statement: A.M., A.S. and E.A. are employed at the Competence Centre on Health Technologies (Tervisetehnoloogiate Arenduskeskus AS) which has developed and im-plemented beREADY test for clinical usage, however the implementation of beREADY for uterine fluid described in this manuscript is not commercialized. Other authors (E.G., P.V., N.Z.) have none.
Funding Statement
This research was funded by Estonian Business and Innovation Agency with decision nr 1.1-5.1/21/2137; the Horizon 2020 innovation (ERIN) grant (no. EU952516) of the European Commission; and the Estonian Research Council (grant PRG1076).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The raw data was published by Giacomini et al 2021.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
Raw data has been already published.
